Please login to the form below
EU
This page shows the latest EU news and features for those working in and with pharma, biotech and healthcare.
EU files WTO dispute with Turkey over pharma laws
on its territory, says the EU, which has now officially launched dispute proceedings via the WTO. ... This is a clear violation of WTO rules and puts many EU jobs at risk,” said Malmström.
Latest news
-
Lynparza set for further expansion with EU approval in breast cancer
Dave Fredrickson, AstraZeneca’s EVP of Oncology, said: “With this approval, Lynparza provides patients throughout the EU with a targeted and oral chemotherapy-free treatment option for a difficult-to-treat
-
Brexit causing ‘significant’ generic drug shortages
Meanwhile, at the political level, Brexit remains at a crisis level, with the UK currently set to leave the EU without a deal in just two days time. ... The EU is, however, expected to agree an extension for the UK at an emergency summit of EU leaders
-
Call for temporary medicines export ban if no-deal Brexit strikes
Banning exports of vital medicines will discourage wholesalers from parallel trading, whereby products that are intended for one market are exported to another EU member state. ... medicines in the same way they do now - whatever the EU exit outcome.”.
-
NICE recommends MSD’s diabetes drug Steglatro
Forxiga recently expanded its use in type 1 diabetes in the EU in overweight or obese patients, claiming the first oral add-on to insulin in this group of patients.
-
UK business: Brexit deadlock causing “frustration and anger”
Businesses were told that by now a Brexit transition period would have been secured and we would have moved on to discussing our future relationship with the EU,” said Morgan. ... The top choice however was a confirmatory referendum, which holds that
More from news
Approximately 130 fully matching, plus 1,964 partially matching documents found.
Latest Intelligence
-
From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
Discussions at ISMPP EU 2019 suggested that, at least for some patients, a more infographic style may be preferred over the standard prose format. ... Therefore, it was exciting to hear at ISMPP EU 2019 that most pharma-sponsored clinical trial
-
Vertex: a vision of treating all CF patients worldwide draws closer
Y. Katherine Xu, an analyst at William Blair, forecast peak annual sales of $10.2bn, up from $8.9bn previously, representing a market share in the US and EU of around
-
The Orkambi row explained
November 2015: EU approval for Vertex’s Orkambi, the first medicine to treat the underlying cause of CF in people aged 12 with two copies of the F508del mutation.
-
#OrkambiNow?
The lack of progress since Orkambi gained EU approval in 2015 has been agonising for CF patients and their families, with the two sides unable to agree a pricing deal for
-
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
That’s because Brexit means the UK will have to fight to secure long-term investment in clinical trials if the UK is to leave the EU’s regulatory environment, with
More from intelligence
Approximately 8 fully matching, plus 162 partially matching documents found.
Latest appointments
-
Open Access Consulting appoints new director
Hurrell joins the group from Evidera, where she worked for over a decade, most recently as vice president and EU practice lead, market access communications.
-
Trio of senior hires joins Syneos Health
the agency and will serve as the head of integrated communications for the EU, partnering with the firm’s customers who work with Syneos for their marketing communications campaigns.
-
Hanover Brussels appoints Aurélie Marchand as account director
Coming from a country where market access and negotiations around pricing and reimbursement can be challenging, I’m eager to bring this experience to the EU level.”. ... Emma Eatwell, director of EU healthcare, Hanover, said: “With her [Marchand]
-
RJW & Partners appoints new director
She joins the firm from pharma service provider ICON, where she served as principal and head of EU pricing and market access.
-
M3 appoints Simon Walker as director of education
M3 EU’s CEO Tim Ringrose said: “I’d like to welcome Simon as our Education Director, a key appointment for M3.
More from appointments
Approximately 2 fully matching, plus 58 partially matching documents found.
Latest from PMHub
-
Research Partnership launches new patient Living with Psoriasis 2017 (EU) report
Living with Psoriasis is a study conducted amongst 615 patients in Europe. The report will consist of 30-minute online interviews with 600 patients and 15 qualitative interviews. It can be purchased as either a 5EU report (sample of 500 patients)
-
News: Therapy Watch launches a new wave of EU tracking in Psoriasis (PsO)
A panel of 40 dermatologists in each of the major EU markets reports on patients on advanced therapies including biologics and small molecule therapies every quarter.
-
Report: Living with RA (EU, Japan and Canada) 2019 reports
Research Partnership launches new patient Living with Rheumatoid Arthritis (EU &Japan) 2019 report. ... Living with Rheumatoid Arthritis (RA) is a quantitative study conducted online amongst 390 patients diagnosed with RA in the 5 EU markets
-
Conference Live: Case study
The solution:. Using our proprietary tool Conference Live, we conducted research at multiple conferences across EU and US for a year.
-
Meet Porterhouse Medical at the ISMPP EU meeting 2019 in London 22 - 23 January
Porterhouse Medical is looking forward to participating in the ISMPP (International Society for Medical Publication Professionals) EU meeting in London tomorrow, entitled: 'Scientific communications in a fast-paced world: Fighting fit
More from PMHub
Approximately 3 fully matching, plus 118 partially matching documents found.
Featured jobs
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Senior / Principal Medical Writer - MedComms - Home Based / Vari...
-
Excellent Remuneration Packages
- Project Manager - Medical Communications – South Wales
-
Excellent Remuneration Package
-
Senior Medical Writer
-
Salary TBC
- Senior Account Director/ Associate Director- Pharma and Life Sci...
-
Competitive salary and benefits
- Experienced / Senior Account Director - Publications - London
-
Up to £80, 000 plus great benefits
- Account Director – London based Medical Communications Agency
-
Excellent Remuneration Package
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Account Manager / Senior Account Manager - Healthcare Advertisin...
-
Excellent Remuneration
-
Account Director, Medical Education
-
Salary TBC
- Senior Account Manager- Pharma and Life Scienes
-
Competitive salary and benefits
-
Director – Healthcare PR
-
Salary TBC
- Project Manager - Digital Healthcare - London
-
Excellent Remuneration Package
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Freelance Medical Writer - Healthcare Advertising - London
-
Employment Type:. Type of Job:. Region:. Salary:. 250 to 330 per day
-
Senior Medical Writer
-
Competitive salary and benefits
Subscribe to our email news alerts
- With Spiriva under pressure, Boehringer moves to bolster pipeline
- Genfit claims FDA breakthrough status for liver disease drug
- Mereo’s shareholders back OncoMed takeover
- Lucid Group announces the appointment of new CFO
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- Q&A: Niels Lund
PMHub
OUTiCO
Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...
Latest intelligence
- From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
- How pharma is progressing their commitment in patient engagement...
- Cuttsy+Cuttsy awarded CPD Platinum by the IPA
- Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
- Breaking Bad
- Six behaviours separate the good brand teams from the bad...
Quick links
Infographics
